These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Progress in psychiatry. Lynch T; Burke RE; Fahn S N Engl J Med; 1994 Jan; 330(4):285-6. PubMed ID: 8272093 [No Abstract] [Full Text] [Related]
54. Tardive Dyskinesia, Lipid Peroxidation and Vitamin E: Peet M1, Laugharne J1, Rangarajan N1, Reynolds GP2, Watson REB2, Cutts AJ2. Academic Department of Psychiatry1, Northern General Hospital, Sheffield S5 7AU; Department of Biomedical Science2, University of Sheffield, Sheffield S10 2TN. J Psychopharmacol; 1992 Jan; 6(1):104. PubMed ID: 22291256 [No Abstract] [Full Text] [Related]
55. Vitamin E and dapsone-induced hemolysis. Smith KC CMAJ; 1994 Jan; 150(2):128. PubMed ID: 8287332 [No Abstract] [Full Text] [Related]
56. More on the use of manganese in dyskinesia. Norris JP; Sams RE Am J Psychiatry; 1977 Dec; 134(12):1448. PubMed ID: 920860 [No Abstract] [Full Text] [Related]
57. Antioxidants as potential therapeutics for neuropsychiatric disorders. Pandya CD; Howell KR; Pillai A Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():214-23. PubMed ID: 23123357 [TBL] [Abstract][Full Text] [Related]
58. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. Yao JK; Reddy RD; van Kammen DP CNS Drugs; 2001; 15(4):287-310. PubMed ID: 11463134 [TBL] [Abstract][Full Text] [Related]
59. Vitamin E treatment of tardive dyskinesia. Corrigan FM; Van Rhijn AG; Mackay AV; Skinner ER; Horrobin DF Am J Psychiatry; 1993 Jun; 150(6):991-2; author reply 992-3. PubMed ID: 8494096 [No Abstract] [Full Text] [Related]
60. Vitamin E treatment of tardive dyskinesia. Holmes VF; D'Alli R; Schweickert L; White R; Brown T; Doraiswamy M; Garcia M Am J Psychiatry; 1993 Jun; 150(6):991; author reply 992-3. PubMed ID: 8494095 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]